SB756050
SB756050 is a selective TGR5 agonist. SB756050 has the potential for type 2 diabetes treatment.
Product Specifications
CAS Number
[447410-57-3]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
G protein-coupled Bile Acid Receptor 1
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/SB756050.html
Purity
98.89
Solubility
DMSO : ≥ 150 mg/mL
Smiles
O=S(N1CCN(S(=O)(C2=CC=C(OC)C(OC)=C2)=O)CCC1)(C3=CC=C(OC)C(OC)=C3)=O
Molecular Formula
C21H28N2O8S2
Molecular Weight
500.59
Precautions
H315, H319, H335
References & Citations
[1]Hodge RJ, et al. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clin Pharmacol Drug Dev. 2013 Jul;2 (3) :213-22.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
245100-ML405 100 µL
CXCL12 (Chemokine (C-X-C Motif) Ligand 12 (Stromal Cell-Derived Factor 1), PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1) (MaxLight 405) discontinued
Ask
View Details 
MBS7194051 Inquire
Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) COA6 Polyclonal Antibody
Ask
View Details